Literature DB >> 29086054

Granulomatosis with polyangiitis (Wegener's granulomatosis): a rare variant of sudden natural death.

Birthe Heitkötter1,2, Cornelius Kuhnen3, Sven Schmidt1, Daniel Wittschieber4.   

Abstract

Granulomatosis with polyangiitis (GPA), formerly known as Wegener's granulomatosis, is the most common form of life-threatening small-vessel vasculitis. Although its exact pathogenesis remains unclear, GPA is believed to belong to the wide complex of autoimmune diseases due to the presence of anti-neutrophil cytoplasmatic antibodies with cytoplasmic staining pattern (c-ANCA) that is expressed in activated neutrophils. GPA predominantly manifests at the upper and lower respiratory tract and the kidneys, but the impairment of multiple organ systems is possible as well. The so-called classical clinical triad of GPA comprises sinusitis, pneumonia, and glomerulonephritis. Despite the fact that there is an elevated risk of mortality for patients suffering from GPA, sudden death due to GPA is a rare and difficult differential diagnosis of sudden natural death in forensic case work. In the present article, the rare case of a 41-year-old male, who died of a sudden death due to previously undiagnosed GPA, is demonstrated. The final diagnosis was feasible by close interdisciplinary collaboration, considering the entire body of findings obtained during autopsy, histopathological investigation, and analysis of the clinical records. Therefore, it remains necessary to point out that especially for rare causes of death, interdisciplinary collaboration is essential in order to concretize the cause of death and exclude rare differential diagnoses of sudden unexpected death of hospitalized patients in forensic case work.

Entities:  

Keywords:  Granulomatosis with polyangiitis; Immunohistochemistry; Right heart failure; Sudden natural death; Wegener’s granulomatosis

Mesh:

Substances:

Year:  2017        PMID: 29086054     DOI: 10.1007/s00414-017-1723-2

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  22 in total

1.  Sudden death and Wegener's granulomatosis of the pituitary.

Authors:  A Woywodt; H Knoblauch; R Kettritz; W Schneider; U Göbel
Journal:  Scand J Rheumatol       Date:  2000       Impact factor: 3.641

Review 2.  Lymphomatoid granulomatosis.

Authors:  Mark Roschewski; Wyndham H Wilson
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

3.  [Vasculitis: New nomenclature of the Chapel Hill consensus conference 2012].

Authors:  K Holl-Ulrich
Journal:  Z Rheumatol       Date:  2014-11       Impact factor: 1.372

Review 4.  Epidemiology of systemic vasculitis.

Authors:  Suzanne E Lane; Richard Watts; David G I Scott
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

Review 5.  Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis).

Authors:  Pamela M K Lutalo; David P D'Cruz
Journal:  J Autoimmun       Date:  2014-01-29       Impact factor: 7.094

Review 6.  [Acute right heart failure. Etiology--pathophysiology--diagnosis--therapy].

Authors:  B Zwissler
Journal:  Anaesthesist       Date:  2000-09       Impact factor: 1.041

Review 7.  What is known about the epidemiology of the vasculitides?

Authors:  Richard A Watts; Suzanne Lane; David G I Scott
Journal:  Best Pract Res Clin Rheumatol       Date:  2005-04       Impact factor: 4.098

Review 8.  Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.

Authors:  A Knight; J Askling; F Granath; P Sparen; A Ekbom
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

9.  Immunohistochemical identification of prevalent right ventricular ischemia causing right heart failure in cases of pulmonary fat embolism.

Authors:  Tony Fracasso; Bernd Karger; Heidi Pfeiffer; Cristina Sauerland; Andreas Schmeling
Journal:  Int J Legal Med       Date:  2009-11-06       Impact factor: 2.686

10.  Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.

Authors:  Mikkel Faurschou; Inge Juul Sorensen; Lene Mellemkjaer; Anne Gitte Rasmussen Loft; Bjarne Svalgaard Thomsen; Niels Tvede; Bo Baslund
Journal:  J Rheumatol       Date:  2007-10-15       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.